Implantation of embryonic cardiomyocytes into the severely damaged myocardium (after 2 infarctions): 23-year follow-up
Автор: Shevchenko Yu.L., Matveev S.A., Gudymovich V.G.
Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center
Рубрика: Обзоры литературы
Статья в выпуске: 2 т.16, 2021 года.
Бесплатный доступ
N this article, we describe our pioneering experience of implantation of human embryonic cardiomyocytes to a patient with severe ischemic heart lesions. In 1998, we injected suspension of human embryonic cardiomyocytes into the myocardium of a 58-year-old male patient during coronary artery bypass surgery. Long follow-up (23 years) shows that the patient, who is currently 81 years old, feels good and has a good quality of life. He has no signs of circulatory insufficiency. No complications associated with cell implantation have ever been reported during this period.
Ischemic heart disease, cell replacement therapy, implantation of embryonic cardiomyocytes
Короткий адрес: https://sciup.org/140257784
IDR: 140257784 | DOI: 10.25881/20728255_2021_16_2_142
Список литературы Implantation of embryonic cardiomyocytes into the severely damaged myocardium (after 2 infarctions): 23-year follow-up
- SHevchenko YUL, Matveev SA, Pinaev GP, et al. Pervyj opyt implantacii embrional'nyh kardiomiocitov (EK) cheloveka v kompleksnom lechenii bol'nyh s ishemicheskoj bolezn'yu serdca. IV Vserossijskij s"ezd SSKH. M.,1998. P.85.
- Шевченко Ю.Л., Матвеев С.А., Пинаев Г.П. и соавт. Первый опыт имплантации эмбриональных кардиомиоцитов (ЭК) человека в комплексном лечении больных с ишемической болезнью сердца. IV Всероссийский съезд ССХ. - М.,1998. - С.85.
- SHevchenko YUL, Matveev SA. Kletochnye tekhnologii v serdechno-sosudistoj hirurgii. M.: Medicina, 2005. 160 р.
- Шевченко Ю.Л., Матвеев С.А. Клеточные технологии в сердечно-сосудистой хирургии. - М.: Медицина, 2005. - 160 с.
- Jackman CP, Shadrin IY, Carlson AL, Bursac N. Human Cardiac Tissue Engineering: From Plu-ripotent Stem Cells to Heart Repair. Curr Opin Chem Eng. 2015 Feb; 7: 57-64. 10.1016/ j.coche.2014.11.004. DOI: 10.1016/j.coche.2014.11.004
- Lee CA, Sinha S, Fitzpatrick E, Dhawan A. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med (Berl). 2018; 96(6): 469-481. DOI: 10.1007/s00109-018-1638-5
- Pepper AR, Pawlick R, Brun A, et al. Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site. Stem Cell Reports. 2017; 8(6): 1689-1700. 10.1016/ j.stemcr.2017.05.004. DOI: 10.1016/j.stemcr.2017.05.004
- Shevchenko YuL. Experimental Validation of Embryonic Cardiomyocyte Implantation in Complex Therapy of Myocardial Failure. Progress in Biomedical Research. 1999; 4(5): 468-474.
